Stock price performance of pharmaceutical companies: pre-vaccine COVID-19 - post-vaccine COVID-19

Authors

  • Henry Daniel Vera Ramírez SENA-SENNOVA
  • Ferly Antonio Valencia Serna SENNOVA CENTRO DE SERVICIOS FINANCIEROS

Keywords:

pharmaceuticals, share price, portfolio, COVID-19

Abstract

This paper performs an analysis of the behaviour of the shares of the main pharmaceutical companies that research to obtain vaccines with a high degree of efficacy for COVID-19. A multiple regression econometric model is proposed, which relates stock prices to the impact of vaccine development on stock prices, including a dummy variable -over the time series- in the analysis. The results suggest significant associations between some pharmaceutical companies that developed vaccines in record time in the period analysed and an impact on the sector’s earnings performance.

Downloads

Download data is not yet available.

Author Biography

  • Ferly Antonio Valencia Serna, SENNOVA CENTRO DE SERVICIOS FINANCIEROS
    Maestría/Magister ESCUELA EUROPEA DE DIRECCIÓN Y EMPRESA
    MBA MAESTRIA EN ADMINISTRACION DE NEGOCIOS
    Abrilde2017 - de
    •  
    Especialización Universidad de La Salle
    ESPECIALIZACION EN GERENCIA FINANCIERA
    Febrerode2000 - Febrerode 2001
    •  
    Pregrado/Universitario UNIVERSIDAD COOPERATIVA DE COLOMBIA
    Administración
    Enerode1995 - Noviembrede 1999
    LA ADMINISTRACION EN COLOMBIA
    •  
    Perfeccionamiento UNIVERSIDAD NACIONAL DE COLOMBIA SEDE BOGOTA
    ECONOMIA
    Enerode2014 - Abrilde 2014
    •  
    Perfeccionamiento INSTITUCIÓN UNIVERSITARIA POLITÉCNICO GRANCOLOMBIANO
    ECONOMIA
    Juniode2013 - Noviembrede 2013
    •  
    Perfeccionamiento UNIVERSIDAD DE CHILE
    ECONOMIA
    Juniode2013 - Agostode 2013
    •  
    Perfeccionamiento UNIVERSIDAD POLITÉCNICA DE VALENCIA - INTERNACIONAL
    INNOVACION PUBLICA Y EMPRESARIAL
    Septiembrede2015 - Noviembrede 2016

References

ABDULLAH M. et al. (2020). "Death and contagious infectious diseases: Impact of the COVID-19 virus on stock market returns". Journal of Behavioral and Experimental Finance, Volume 27, pp. https://doi.org/10.1016/j.jbef.2020.100326

ARAVIND, M. AND MANOJKRISHNAN, C.G. (2020). "COVID 19: Effect on leading pharmaceutical stocks listed with NSE". International Journal of Research in Pharmaceutical Sciences. 11(SPL) (1): 31-36. https://doi.org/10.26452/ijrps.v11iSPL1.2014

BENIGER, J. R., AND D. L. ROBYN. (1978). Quantitative graphics in statistics: A brief history. American Statistician 32. https://doi.org/10.2307/2683467

COX, N. J. (2005). Speaking Stata: Density probability plots. Stata Journal 5: 259-273. 1-11. https://doi.org/10.1177/1536867X0500500210

DHRYMES, P. (1994). Topics in Advanced Econometrics. Volume II. Linear and Nonlinear Simultaneous Equations. Springer-Verlag. https://doi.org/10.1007/978-1-4612-4302-1

FAMA, E.F. AND FRENCH, K.R. (1988). "Permanent and Temporary Components of Stocks prices". Journal of Political Economy, 96:246-273. https://doi.org/10.1086/261535

GRABOWSKI, H AND VERNON, J (1990). "A New Look at the Returns and Risks to Pharmaceutical R&D". Management Science, vol 36, 7, 767-885. https://doi.org/10.1287/mnsc.36.7.804

HALUNGA, A, ORME, C AND YAMAGATA, T (2017). "A Heteroskedasticity Robust Breusch-Pagan Test for Contemporaneous Correlation in Dynamic Panel Data Models". Journal of Econometrics. pp. 209-230. https://doi.org/10.1016/j.jeconom.2016.12.005

HARRISON, D. A. (2005). Stata tip 20: Generating histogram bin variables. Stata Journal 5: 280-281. https://doi.org/10.1177/1536867X0500500213

IQBAL KHAN, K. (2012). "Effect of Dividends on Stock Prices- A Case of Chemical and Pharmaceutical Industry of Pakistan". Management, 2(5): 141-148. https://doi.org/10.5923/j.mm.20120205.02

KAUSHIK, M. et al. (2005). "Statistical Properties of Business Firms Structure and Growth". arXiv:physics/0502081 [physics.soc-ph]

KEBRIAEE-ZADEH, A. et al. (2013). "Fundamentals and Stock Return in Pharmaceutical Companies: a Panel Data Model of Iranian Industry". Iranian Journal of Pharmaceutical Sciences 9 (1). pp. 55-60.

KOLA, I, AND LANDIS, J. (2004). "Can the pharmaceutical industry reduce attrition rates?" Nat Rev Drug Discov 3, pp. 711-716. https://doi.org/10.1038/nrd1470

MAHAN, V. L. (2014). "Clinical Trial Phases". International Journal of Clinical Medicine, 5, 1374-1383. https://doi.org/10.4236/ijcm.2014.521175

MUNOS, B. H. CHIN, W. W. (2011). "How to Revive Breakthrough Innovation in the Pharmaceutical Industry". Sci. Transl. Med. 3, 89-116. https://doi.org/10.1126/scitranslmed.3002273

PEARSON, K. (1895). Contributions to the mathematical theory of evolution-II. Skew variation in homogeneous material. Philosophical Transactions of the Royal Society of London, Series A 186: 343-414. https://doi.org/10.1098/rsta.1895.0010

QIOA, F, AND YAN, Y (2020). "How does stock market reflect the change in economic demand? A study on the industry-specific volatility spillover networks of China's stock market during the outbreak of COVID-19". arXiv:2007.07487v1 [q-fin.GN] https://doi.org/10.18488/journal.aefr.2020.1011.1321.1341

SAYEMA, H. et al. (2005). "How Volatile are the Stocks of the Pharmaceutical Companies of Bangladesh? Some Evidences from the Market Model". Bank Parikrama, vol. XXX, No. 2, Bangladesh Institute of Bank Management, pp 1-23. DOI: 10.2139/ssrn.1550561 https://doi.org/10.2139/ssrn.1550561

SORNETTE, D. (2000). "Economy of Scales in R&D with Block-busters". arXiv:cond-mat/0001434 31

SCOTT, D, SAINI, A, AND ZAMAN, T. (2018) "Picking Winners: A Data Driven Approach to Evaluating the Quality of Startup Companies". arXiv:1706.04229v2 [stat.AP] 8 Jul 2018

SPEIGHTS, K (2021). Investing in pharmaceutical Stocks. Recovered: https://www.fool.com/investing/stock-market/market-sectors/healthcare/pharmaceutical-stocks/

Downloads

Published

2022-01-31

Issue

Número 1/2022, Época 2

Section

SPECIAL ISSUE 01/2022. Covid, State and Market...(II)

License

Copyright (c) 2022 Universidad de Jaén

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

  1. Authors maintain the copyright, but they guarantee the journal its right for publication, that is under Creative Commons Licence, permitting others share the work, whereas clearly indicating the author and the first publication of the journal.
  2. Authors could adopt non-exclusive licence agreements for delivering the published version, whereas clearly indicating the first publishing in Revista de Estudios Empresariales. Second Era.
  3. Authors are encouraged to spread their works through Internet before and during the sending process, in order to make interesting scientific discussions that could increase the cites of the published work (Open Citation Project).

Revista de Estudios Empresariales. Second Era, uses PKP Preservation Network (PN).

How to Cite

Vera Ramírez, H. D., & Valencia Serna, F. A. (2022). Stock price performance of pharmaceutical companies: pre-vaccine COVID-19 - post-vaccine COVID-19. Revista De Estudios Empresariales. Second Era, 1, 68-93. https://revistaselectronicas.ujaen.es/index.php/REE/article/view/6638